Higher circulating levels of LEP have been found associated with breast cancer risk.18,19 It is noteworthy that although the LEP and LEP receptor (LEPR) genes have a very-low expression in normal breast tissue, both genes are highly expressed in breast tumor 20,21 in response to high levels of estrogens, insulin, and IGF-1.21 This evidence concerns the gene INS and breast carcinoma.